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A B S T R A C T
The association between aplastic crisis and human parvovirus (HPV) B19 infection has been described in patients
with hereditary spherocytosis (HS). Most cases of aplastic crisis in patients with HS induced by HPV B19 have been re-
ported in children and adolescents. In this paper, we describe an aplastic crisis induced by HPV B19 in the 34 year old fe-
male as an initial presentation of HS. Although other viral illnesses cause some decompensation in HS, the anemia is
rarely as profound as seen in acute HPV B19 infections15.
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Introduction
Human parvovirus (HPV) B19 is a small, non-envel-
oped single-stranded DNA virus, which belongs to the
Parvovirus genus within the Parvoviridae family. It was
first discovered in 1975 while screening units of blood for
hepatitis B virus in asymptomatic donors1. HPV B19 in-
fection is common worldwide, and majority of individuals
who contract the virus are infected by the age of fifteen2.
The most common means of transmission is exposure to
infected respiratory droplets. Viremia occurs 7 to 10 days
after exposure to B19 and usually lasts approximately
five days3. HPV B19 infection can lead to a variety of clin-
ical manifestations dependent on the underlying host. In
children, parvovirus B19 can cause erythema infectio-
sum, a mild febrile illness with rash while patients with
underlying hemolytic disorders (such as sickle cell dis-
ease, erythrocyte enzyme deficiencies, hereditary sphe-
rocytosis, thalassemias, paroxysmal nocturnal hemoglo-
binuria, and autoimmune hemolysis) can develop tran-
sient aplastic crisis and infection during pregnancy can
lead to fetal death3. Severe manifestations of HPV B19
viremia relate mostly to the propensity of virus to infect
and lyse erythroid progenitor cells of the bone marrow4.
HPV B19 infection in most instances causes transient
aplastic crisis, developing suddenly in patients with chro-
nic hemolytic disease. Infected patients have severe reti-
culocytopenia lasting seven to ten days, and their bone
marrow contains no erythroid precursor cells despite a
normal myeloid series4. Giant pronormoblasts, hallmark
of cytopathic effects of parvovirus B 19, often appear in
the marrow5.
Virally induced aplastic crisis brings many patients to
medical attention, particularly asymptomatic hereditary
spherocytosis (HS) patients with normally compensated
hemolysis6. Because aplastic crises usually last 10 to 14
days (about half the life span of HS red cells), the hemo-
globin value typically falls to about half its usual level be-
fore recovery occurs. In patients with severe HS, the ane-
mia may be profound, requiring hospitalization and
transfusion5. However, most cases of aplastic crisis in pa-
tients with HS induced by parvovirus B19 have been re-
ported in children and adolescents. In this paper, we de-
scribe an aplastic crisis induced by parvovirus B19 in the
34 year old female as an initial presentation of hereditary
spherocytosis.
Case Report
Thirty four years old female was admitted to the hos-
pital because of severe normocytic anemia and febrile
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condition. From previous medical history it was found
she had tonsillectomy at the age of two, and at the age
twenty-one abdominal ultrasound revealed discreet spleen
enlargement. She was not married and had no children.
Five days before admission to hospital she had nausea,
headache, chills and fever up to 39.6°C. Next few days
she felt better but was still febrile up to 38°C. Day before
hospitalization she was observed in Clinic for infective
diseases where anemia was detected: white blood count
(WBC) 4.1x109/L; red blood count (RBC) 2.79x109/L; he-
moglobin (Hb) 99 g/L; hematocrit (Hct) 0.25 L/L; mean
corpuscular volume (MCV) 90.2 fL; mean corpuscular he-
moglobin (MCH) 35.3 pg; mean corpuscular hemoglobin
concentration – MCHC 391 g/L (normal ranges 315–360
g/L); red cell distribution width (RDW) 14.8%; platelet
count (Plt) 143x109/L) with high serum lactate dehydro-
genase – LDH concentration (647 U/L), bilirubin (49.2
ìmol/L), aspartate aminotransferase – AST (190 U/L),
alanine aminotransferase – ALT (133 U/L) and almost
normal C-reactive protein – CRP (13.1 mg/L). On the
next day complete blood count worsened [WBC 2.7x109/L;
RBC 2.02 x109/L; Hb 66 g/L; Hct 0.18 L/L; MCV 89 pg;
MCHC 369g/L (normal ranges 320–345 g/L); Plt
123x109/L], hemolytic anemia was suspected and patient
was sent to our Clinic for hospitalization. Prominent fea-
tures at admission were pallor and palpable liver and
spleen four cm from the costal margin. She was subfeb-
rile (37°C), without peripheral lymph node enlargement.
The day after admission her hemoglobin and Hct had
fallen to 52 g/L and 0.14 L/L and platelets to 122x109/L.
Absolute reticulocyte count (Rtc) was 39.8x109/L (normal
ranges 22–97x109/L) and relative 2.33% (normal ranges
0.5–2.16%). Liver function tests worsened; AST 230 U/L,
ALT 232 U/L, bilirubin 45.3 mmol/L, and LDH 626 U/L.
Serum iron (40.2 mmol/L), iron saturation (78%) and
ferritin (>1500 ng/mL) were increased, and haptoglobin
had been decreased to <0.07 g/L (normal ranges 0.30–2.0
g/L). The direct antiglobulin test was negative, and os-
motic fragility of patient’s red cells was increased. The
peripheral blood smear revealed anisocytosis and poi-
kilocytosis with some spherocytes (Figure 1). Bone mar-
row aspirate smears in accordance with aplasia of red
line showed extremely reduced erythropoesis without
signs of maturation (Figure 2). HPV B19 IgM and IgG
were both positive. Abdominal ultrasound revealed mul-
tiple gallstones and spleen enlargement (139 mm). Im-
munophenotypisation of peripheral blood for CD55 and
CD59 were normal, excluding paroxysmal nocturnal he-
moglobinuria as a potential cause of anemia. At second
day of hospitalization patient received two units of pac-
ked red blood cells (560 mL), with marked clinical im-
provement. The hemoglobin was stabile for the next
seven days (Hb:74 g/L). On eight day rise in reticulocytes
to 19.7% and platelet count to 596x109/L was noticed,
and on tenth day hemoglobin level was 86 g/L. She was
discharged ten days latter when her hemoglobin reached
100 g/L and Hct 0.28 g/L, with Rtc of 11.6%. Level of
aminotransferases and LDH normalized, but bilirubin
was without change.
Discussion and Conclusion
Human Parvovirus B19 typically infects erythroid
progenitor cells and inhibits erythropoesis, leading to
acute cessation of erytrocyte production7. In addition to
reticulocytopenia, both neutropenia and thrombocyto-
penia associated with or without hemolytic disorders
have been observed during HPV B19 infection8,9, and
were also seen in our patient. When infected with the vi-
rus, immunocompetent subjects may develop some de-
gree of anemia, but normal erythrocyte life span pre-
vents them from becoming significantly anemic10. In
conditions such as hereditary spherocytosis, the short-
ened life span of the erythrocytes can lead to severe and
abrupt development of anemia if erythropoesis is inter-
rupted. Giant pronormoblasts on peripheral blood smear
or in the bone marrow aspirate are suggestive of parvovi-
rus B19 infection but are not diagnostic11. During the
spontaneous recovery marrow may display cohorts of
early erythroid cells. Occasionally, there are large, in-
tensely basophilic cells termed giant pronormoblasts5. In
our patient we did not find giant pronormoblasts because
bone marrow aspirate was done during early phase of ill-
ness, when marrow is depleted of all erythroid elements.
There are two types of diagnostic tests to confirm par-
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Fig. 1. Peripheral blood smear in HS patient reveal anisocytosis
and poikilocytosis with some spherocytes.
Fig. 2. Bone marrow aspirate smears show extremly reduce eryt-
hropoesis without signs of maturation and giant pronormoblasts.
vovirus B19 infection: B19-specific antibody testing and
viral DNA testing. Parvovirus B19-specific IgM antibod-
ies are detected at day 10 through 12 and can persist for
up to five months. Specific IgG antibodies are detectable
about 15 days post-infection and persist long-term3. Se-
rologic test is incapable of detecting acute infection at
the onset of symptoms, before the appearance of immu-
nologic response12. In the case of our patient, infection
with HPV B19 was confirmed by detection of anti-HPV
IgM antibodies on a serologic test requested on the 14th
day of hospitalization. Hereditary spherocytosis (HS) is
the most common hereditary hemolytic anemia among
people of northern European descent. It is caused by
membrane protein defects resulting in cytoskeleton in-
stability. The classic laboratory features of HS include
anemia (which is of variable degree), reticulocytosis, an
increased MCHC, spherocytes on the peripheral blood
smear, hyperbilirubinemia and abnormal results of the
osmotic fragility test13. All of these were found in our pa-
tient. She also had gallstones, a very common finding
during young age of these patients, and discreet sple-
nomegaly. The length of time between infection and on-
set of aplastic crisis is known to be eight to ten days. The
interval between the onset of symptoms and reappear-
ance of reticulocytes in peripheral blood ranges from five
to twenty days14. The classical clinical picture was seen
in our patient. Such crises may be clinically severe and
require prompt red cell transfusion. This happened with
our patient who was transfused with two packs of red
blood cells.
Adults who remain undiagnosed for HS usually have
a very mild form, and they live with the HS remaining
undetected until challenged by an environmental stre-
ssor. Anemia is generally not present because the bone
marrow is able to fully compensate for the persistent de-
struction of red cells. They are often not diagnosed until
latter in life, usually due to hemolytic or aplastic episodes
triggered by infection13. It is perhaps surprising that the
diagnosis of HS is not always considered in a setting of
gallstones and splenomegaly in adult life15.
In this report we described a woman with previously
undiagnosed hereditary spherocytosis presenting with
aplastic crisis induced by HPV B19 infection. Although
other viral illnesses cause some degree of decompen-
sation in HS, the anemia is very rarely as profound as
seen in acute parvovirus infections15.
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APLASTI^NA KRIZA INDUCIRANA HUMANIM PARVOVIRUSOM B19 KAO INICIJALNA
PREZENTACIJA HEREDITARNE SFEROCITOZE
S A @ E T A K
Povezanost izme|u aplasti~ne krize i infekcije humanim parvovirusom (HPV) opisana je u bolesnika s hereditarnom
sferocitozom (HS). Ve}ina slu~ajeva aplasti~ne krize u takvih bolesnika opisana je u djece i adolescenata. U ~lanku
opisujemo aplasti~nu krizu induciranu s HPV B19 u 34-godi{nje `ene kao inicijalnu prezentaciju HS. Orija{ki pro-
normoblasti, obilje`je su citopatskog efekta HPV B19 i ~esto se nalaze u ko{tanoj sr`i. Iako i druge virusne infekcije
uzrokuju dekompenzaciju u HS, anemija je rijetko tako izra`ena kao u akutnim HPV B19 infekcijama.
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